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Maria Osikowicz1†, Geraldine Longo1†, Simon Allard1, A Claudio Cuello1,2,3† and Alfredo Ribeiro-da-Silva1,2*†Correction
It was brought to my attention that the representative
bands on Figure 1A, of this work [1] are from a different
experiment than the one described and do not represent
the quantified data. The quantification and bar graphs
are correct, but the representative bands should be re-
placed by the ones from the corresponding experiment.
The error was made during figure preparation. We
apologize for the complication and thank you for your
help on this issue. The attached file should replace the
one that was published. The Figure legend (reproduced
below) stays the same.* Correspondence: alfredo.ribeirodasilva@mcgill.ca
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Figure 1 MMP-2/9 inhibitor administration altered the protein levels of NGF and MMP-9 in the skin of naive rats. Western blot analysis
performed on the glabrous skin samples following 14 days of repeated MMP-2/9 inhibitor (MMP-2/9I.; 20 μg, i.pl.) administration showed a significant
increase in the protein levels of mature NGF (mNGF) (A), with no influence on the protein level of the precursor proNGF (B). Repeated administration
of MMP-2/9I. (20 μg, i.pl.) significantly reduced the protein levels of MMP-9 (C) in the glabrous skin. Examples of representative western blots are
presented in the upper panels A, B and C. The densitometry results are presented as the mean ± SEM from all samples. Inter-group differences were
analyzed by ANOVA with a Bonferroni’s multiple comparison test. ***p < 0.001 indicates a significant difference as compared to glabrous skin sample
of chronic vehicle-treated (V) naive rats. The interrupted line on the graphs indicates protein analyses for mNGF, proNGF or MMP-9 in the contralateral
glabrous skin of chronic MMP-2/9I.-treated naïve rats.
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